InvestorsHub Logo
Followers 0
Posts 1
Boards Moderated 0
Alias Born 07/01/2025

Re: None

Tuesday, 07/01/2025 12:55:51 AM

Tuesday, July 01, 2025 12:55:51 AM

Post# of 724
NY, Jon, have lurked for over 2 years and appreciate your commentary. I felt the need to make an account today when I saw the news on this ABBV acquisition of Capstan Therapeutics.

How does this early trial announced days before their acquisition compare FT819 prospects? I have rarely seen M&A so early in pre-clinical/Ph1. FATE seems to have received favorable sentiment after this news. I appreciate your insight as your scientific intuition is far beyond my understanding.

https://news.abbvie.com/2025-06-30-AbbVie-to-Acquire-Capstan-Therapeutics,-Further-Strengthening-Commitment-to-Transforming-Patient-Care-in-Immunology
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News